Brant A Inman

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. doi request reprint The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Hyperthermia 29:206-10. 2013
  2. doi request reprint Novel immunotherapeutic strategies in development for renal cell carcinoma
    Brant A Inman
    Duke University Medical Center, Durham, NC, USA Electronic address
    Eur Urol 63:881-9. 2013
  3. pmc An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    BJU Int 110:375-81. 2012
  4. pmc Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer
    Lee W Jones
    Duke University Medical Center, Durham, NC, USA
    BMC Cancer 10:531. 2010
  5. pmc Miniature microwave applicator for murine bladder hyperthermia studies
    Sara Salahi
    Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA
    Int J Hyperthermia 28:456-65. 2012
  6. ncbi request reprint Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis
    Michael R Abern
    From the Division of Urology, Duke University Medical Center, Durham, North Carolina
    J Natl Compr Canc Netw 11:477-84. 2013

Collaborators

Detail Information

Publications6

  1. doi request reprint The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Hyperthermia 29:206-10. 2013
    ..This value is necessary for accurate modelling of fluid mechanics and heat transfer during hyperthermia treatments of bladder cancer...
  2. doi request reprint Novel immunotherapeutic strategies in development for renal cell carcinoma
    Brant A Inman
    Duke University Medical Center, Durham, NC, USA Electronic address
    Eur Urol 63:881-9. 2013
    ..The purpose of this report is to review immunotherapies under investigation for patients with renal cell carcinoma (RCC), the most common form of kidney cancer, for which the incidence and mortality rate continue to increase...
  3. pmc An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    BJU Int 110:375-81. 2012
    ..To determine whether prostate-specific antigen velocity (PSA-V), PSA doubling time (PSA-DT), or PSA percentage change (PSA-PC) add incremental information to PSA alone for community-based men undergoing prostate cancer (PCa) screening...
  4. pmc Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer
    Lee W Jones
    Duke University Medical Center, Durham, NC, USA
    BMC Cancer 10:531. 2010
    ....
  5. pmc Miniature microwave applicator for murine bladder hyperthermia studies
    Sara Salahi
    Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA
    Int J Hyperthermia 28:456-65. 2012
    ..Of particular interest is a device that can selectively heat murine bladder...
  6. ncbi request reprint Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis
    Michael R Abern
    From the Division of Urology, Duke University Medical Center, Durham, North Carolina
    J Natl Compr Canc Netw 11:477-84. 2013
    ..A single dose of IVC administered within 24 hours of TUR of NMIBC was found to result in a reduction in tumor recurrence (RR, 0.67; 95% CI, 0.56-0.79). Patients with higher-risk tumor features seem to benefit at a similar rate...